News for TAPIMMUNE INC (TPIV)

News for TAPIMMUNE INC
Date Headline
Apr 19, 2017 08:30 AM NetworkNewsWire Announces Publication Highlighting Advances in Cancer Therapy
Apr 07, 2017 08:30 AM NetworkNewsWire Announces Publication Highlighting Innovative Companies Developing Promising Cancer Treatments
Mar 24, 2017 08:30 AM NetworkNewsWire Announces Publication of Discussion on the Potential of Immunotherapies for Cancer Treatment
Mar 22, 2017 11:00 AM TapImmune to Participate in Two Upcoming Investor and Industry Conferences
Mar 14, 2017 04:05 PM TapImmune Provides Year End 2016 Corporate and Clinical Update
Mar 14, 2017 09:15 AM TapImmune Announces Fully Funded Phase 2 Clinical Study of HER2-Targeted Vaccine in Early Breast Cancer
Mar 08, 2017 09:15 AM TapImmune to Host Inaugural Quarterly Business Update Conference Call and Webcast
Feb 15, 2017 09:15 AM TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review
Feb 09, 2017 08:30 AM TapImmune, Inc. Presentation Now Available for On-Demand Viewing
Feb 07, 2017 09:15 AM TapImmune Expands Intellectual Property On PolyStartâ„¢ Platform For Use In Next-Generation T-Cell Vaccines